Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer

被引：0
|
作者：
Chiang, Andrew Szehsun [1 ]
Loblaw, D. Andrew [1 ]
Jethava, Vibhuti [1 ]
Sethukavalan, Perakaa [1 ]
Zhang, Liying [1 ]
Vesprini, Danny [1 ]
Mamedov, Alexandre [1 ]
Nam, Robert [1 ]
Klotz, Laurence [1 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Active surveillance for low-risk prostate cancer
    Hadjipavlou, Marios
    Promponas, John
    Madaan, Sanjeev
    [J]. JOURNAL OF CLINICAL UROLOGY, 2015, 8 (06) : 420 - 428
  • [22] HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
    Webb, Lindsey T.
    Diaz, Gabriela M.
    Rahman, Syed N.
    Khajir, Ghazal
    Sprenkle, Preston C.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E504 - E505
  • [23] Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?
    Richard M. Hoffman
    Richard G. Roberts
    Michael J. Barry
    [J]. Journal of General Internal Medicine, 2011, 26 : 798 - 801
  • [24] PSA VELOCITY IN MEN STARTING 5-ALPHA- REDUCTASE INHIBITORS AT THE TIME OF STARTING ACTIVE SURVEILLANCE IS A PREDICTOR OF PATHOLOGICAL PROGRESSION IN LOW-RISK PROSTATE CANCER
    Timilshina, Narhari
    Alibhai, Shabbir
    Komisarenko, Maria
    Martin, Lisa
    Grewal, Ruby
    Hamilton, Rob
    Kulkarni, Girish
    Zlotta, Alexandre
    Fleshner, Neil
    Finelli, Antonio
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1053 - E1053
  • [25] Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors
    Fradet, Vincent
    Toren, Paul
    Nguile-Makao, Moliere
    Lodde, Michele
    Levesque, Jerome
    Leger, Caroline
    Caron, Andre
    Bergeron, Alain
    Ben-Zvi, Tal
    Lacombe, Louis
    Pouliot, Frederic
    Tiguert, Rabi
    Dujardin, Thierry
    Fradet, Yves
    [J]. BJU INTERNATIONAL, 2018, 121 (03) : 399 - 404
  • [26] Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?
    Hoffman, Richard M.
    Roberts, Richard G.
    Barry, Michael J.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (07) : 798 - 801
  • [27] Prognostic influence of 5 alpha reductase inhibitors in patients with localized prostate cancer under active surveillance
    Ozkan, Tayyar Alp
    Cebeci, Oguz Ozden
    Cevik, Ibrahim
    Dillioglugil, Ozdal
    [J]. TURKISH JOURNAL OF UROLOGY, 2018, 44 (02): : 132 - 137
  • [28] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
    Dunst, Juergen
    Krug, David
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
  • [29] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 241A - 241A
  • [30] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 241A - 241A
12345